IRIS
BURLONE, MICHELA Emma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.241
NA - Nord America 1.161
AS - Asia 740
SA - Sud America 141
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.307
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.127
IE - Irlanda 300
SG - Singapore 231
DE - Germania 185
IT - Italia 163
CN - Cina 159
SE - Svezia 143
BR - Brasile 117
HK - Hong Kong 117
UA - Ucraina 102
FR - Francia 97
RU - Federazione Russa 82
IN - India 76
VN - Vietnam 76
FI - Finlandia 50
GB - Regno Unito 36
KR - Corea 25
AT - Austria 21
CA - Canada 20
ID - Indonesia 18
BE - Belgio 15
MX - Messico 12
BD - Bangladesh 11
BJ - Benin 11
PL - Polonia 11
NL - Olanda 10
CZ - Repubblica Ceca 8
ES - Italia 7
TR - Turchia 7
AR - Argentina 6
EC - Ecuador 6
IR - Iran 6
KE - Kenya 5
JP - Giappone 4
ZA - Sudafrica 4
CH - Svizzera 3
CL - Cile 3
VE - Venezuela 3
AZ - Azerbaigian 2
EU - Europa 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
DO - Repubblica Dominicana 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
RO - Romania 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.307
Salva come PNG Salva come JPEG
Città #
Dublin 297
Jacksonville 175
Hong Kong 117
Chandler 89
Dearborn 82
Singapore 79
Ashburn 75
Beijing 72
Ann Arbor 67
Wilmington 54
Piemonte 39
Los Angeles 37
Novara 36
Princeton 34
Lawrence 33
Munich 33
Moscow 27
Buffalo 25
Seoul 25
Ho Chi Minh City 18
San Mateo 18
Hanoi 17
São Paulo 17
Brussels 15
Andover 14
Milan 13
Nuremberg 13
Santa Clara 13
Jakarta 12
New York 12
Cotonou 11
Frankfurt am Main 11
Dong Ket 10
Helsinki 10
Houston 10
Nanjing 9
Atlanta 8
Brno 8
Brooklyn 8
Denver 8
Bremen 7
Dallas 7
Hefei 7
Phoenix 7
Seattle 7
Amsterdam 6
Orem 6
Poplar 6
Redondo Beach 6
Tianjin 6
Turin 6
Ankara 5
Augusta 5
Bexley 5
Falkenstein 5
Jinan 5
Kunming 5
Nairobi 5
Porto Alegre 5
Toronto 5
Warsaw 5
Boardman 4
Boston 4
Chicago 4
Curitiba 4
Da Nang 4
Leawood 4
London 4
Monmouth Junction 4
Montreal 4
Mumbai 4
Rome 4
Stockholm 4
Tokyo 4
Turku 4
Vienna 4
Woodbridge 4
Biên Hòa 3
Brasília 3
Calgary 3
Cassano Magnago 3
Chennai 3
Dhaka 3
Fairfield 3
Hải Dương 3
Johannesburg 3
Kraków 3
Magenta 3
Manchester 3
Mexico City 3
Norwalk 3
Querétaro 3
Quito 3
Ribeirão Preto 3
Rio de Janeiro 3
Roubaix 3
San Jose 3
Strasbourg 3
Ardabil 2
Baku 2
Totale 1.903
Salva come PNG Salva come JPEG
Nome #
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study 133
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 129
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 119
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 109
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib 108
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 105
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 103
Influence of age on sex-related differences among patients with hepatitis C. 101
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 100
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 100
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 95
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy] 92
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 91
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 89
Recent advances in HCV entry 89
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 88
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 88
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 87
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 87
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 86
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 85
Interferon-stimulated gene pathways in the treatment of viral hepatitis 82
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 82
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 78
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 76
Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study 74
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 73
The albumin–bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development 71
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. 69
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 67
GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 66
Toxocara encephalitis presenting with autonomous nervous system involvement 65
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 65
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 62
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression 55
PANCREATOBILIARY REFLUX RESULTING IN PANCREATIC ASCITES AND CHOLEPERITONEUM AFTER GALLBLADDER PERFORATION 53
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 50
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development 46
Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis 44
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 38
From MASH to HCC: the role of Gas6/TAM receptors 36
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 36
Totale 3.372
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.087
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 0 23 37 3 35 11 35 14
2021/2022234 4 13 31 18 15 2 20 12 16 22 32 49
2022/2023641 60 33 41 7 44 62 17 36 307 1 23 10
2023/2024240 24 39 21 0 35 2 42 6 1 4 27 39
2024/2025537 17 3 41 7 17 32 58 51 128 57 17 109
2025/2026830 98 91 121 321 184 15 0 0 0 0 0 0
Totale 3.372